Fingerprint
Dive into the research topics of 'Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically